213 related articles for article (PubMed ID: 35667688)
21. MicroRNAs (miRNAs) and Long Non-Coding RNAs (lncRNAs) as New Tools for Cancer Therapy: First Steps from Bench to Bedside.
Ratti M; Lampis A; Ghidini M; Salati M; Mirchev MB; Valeri N; Hahne JC
Target Oncol; 2020 Jun; 15(3):261-278. PubMed ID: 32451752
[TBL] [Abstract][Full Text] [Related]
22. Regulation of Ferroptosis by Non-Coding RNAs: Mechanistic Insights.
Farooqi AA; Kapanova G; Kalmakhanov S; Kussainov AZ; Datkhayeva Z
J Pharmacol Exp Ther; 2023 Jan; 384(1):20-27. PubMed ID: 36507844
[TBL] [Abstract][Full Text] [Related]
23. Targeting Keap1 by miR-626 protects retinal pigment epithelium cells from oxidative injury by activating Nrf2 signaling.
Xu XZ; Tang Y; Cheng LB; Yao J; Jiang Q; Li KR; Zhen YF
Free Radic Biol Med; 2019 Nov; 143():387-396. PubMed ID: 31446056
[TBL] [Abstract][Full Text] [Related]
24. Exosomal microRNAs and exosomal long non-coding RNAs in gynecologic cancers.
Hashemipour M; Boroumand H; Mollazadeh S; Tajiknia V; Nourollahzadeh Z; Rohani Borj M; Pourghadamyari H; Rahimian N; Hamblin MR; Mirzaei H
Gynecol Oncol; 2021 Apr; 161(1):314-327. PubMed ID: 33581845
[TBL] [Abstract][Full Text] [Related]
25. Spotlight on Exosomal Non-Coding RNAs in Breast Cancer: An In Silico Analysis to Identify Potential lncRNA/circRNA-miRNA-Target Axis.
Ashekyan O; Abdallah S; Shoukari AA; Chamandi G; Choubassy H; Itani ARS; Alwan N; Nasr R
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955480
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic versus Genetic Deregulation of the KEAP1/NRF2 Axis in Solid Tumors: Focus on Methylation and Noncoding RNAs.
Fabrizio FP; Sparaneo A; Trombetta D; Muscarella LA
Oxid Med Cell Longev; 2018; 2018():2492063. PubMed ID: 29643973
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of miR-200a protects cardiomyocytes against hypoxia-induced apoptosis by modulating the kelch-like ECH-associated protein 1-nuclear factor erythroid 2-related factor 2 signaling axis.
Sun X; Zuo H; Liu C; Yang Y
Int J Mol Med; 2016 Oct; 38(4):1303-11. PubMed ID: 27573160
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of non-coding RNA-modulated alternative splicing in cancer.
Wang X; Hua J; Li J; Zhang J; Dzakah EE; Cao G; Lin W
RNA Biol; 2022; 19(1):541-547. PubMed ID: 35427215
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-200a controls Nrf2 activation by target Keap1 in hepatic stellate cell proliferation and fibrosis.
Yang JJ; Tao H; Hu W; Liu LP; Shi KH; Deng ZY; Li J
Cell Signal; 2014 Nov; 26(11):2381-9. PubMed ID: 25049078
[TBL] [Abstract][Full Text] [Related]
30. NRF2-driven miR-125B1 and miR-29B1 transcriptional regulation controls a novel anti-apoptotic miRNA regulatory network for AML survival.
Shah NM; Zaitseva L; Bowles KM; MacEwan DJ; Rushworth SA
Cell Death Differ; 2015 Apr; 22(4):654-64. PubMed ID: 25323587
[TBL] [Abstract][Full Text] [Related]
31. Understanding the role of NRF2-regulated miRNAs in human malignancies.
Shah NM; Rushworth SA; Murray MY; Bowles KM; MacEwan DJ
Oncotarget; 2013 Aug; 4(8):1130-42. PubMed ID: 24029073
[TBL] [Abstract][Full Text] [Related]
32. The functional significance and cross-talk of non-coding RNAs in triple negative and quadruple negative breast cancer.
Paul U; Banerjee S
Mol Biol Rep; 2022 Jul; 49(7):6899-6918. PubMed ID: 35235157
[TBL] [Abstract][Full Text] [Related]
33. Transcription factor Nrf2 binds to circRNAPIBF1 to regulate SOD2 in lung adenocarcinoma progression.
Zhang Z; Chen Q; Huang C; Rao D; Sang C; Zhu S; Gu L; Xie C; Tang Z; Xu X
Mol Carcinog; 2022 Dec; 61(12):1161-1176. PubMed ID: 36193777
[TBL] [Abstract][Full Text] [Related]
34. Non-coding RNAs: long non-coding RNAs and microRNAs in endocrine-related cancers.
Klinge CM
Endocr Relat Cancer; 2018 Apr; 25(4):R259-R282. PubMed ID: 29440232
[TBL] [Abstract][Full Text] [Related]
35. Long noncoding RNA LINC00239 inhibits ferroptosis in colorectal cancer by binding to Keap1 to stabilize Nrf2.
Han Y; Gao X; Wu N; Jin Y; Zhou H; Wang W; Liu H; Chu Y; Cao J; Jiang M; Yang S; Shi Y; Xie X; Chen F; Han Y; Qin W; Xu B; Liang J
Cell Death Dis; 2022 Aug; 13(8):742. PubMed ID: 36038548
[TBL] [Abstract][Full Text] [Related]
36. Novel insights into the interaction between long non-coding RNAs and microRNAs in glioma.
Ebrahimpour A; Sarfi M; Rezatabar S; Tehrani SS
Mol Cell Biochem; 2021 Jun; 476(6):2317-2335. PubMed ID: 33582947
[TBL] [Abstract][Full Text] [Related]
37. Long Non-Coding RNA PVT1 Regulates the Resistance of the Breast Cancer Cell Line MDA-MB-231 to Doxorubicin via Nrf2.
Luo Y; Zhang W; Xu L; Chen Y; Xu Y; Yuan L
Technol Cancer Res Treat; 2020; 19():1533033820980763. PubMed ID: 33327894
[TBL] [Abstract][Full Text] [Related]
38. Long Noncoding RNA ANPODRT Overexpression Protects Nucleus Pulposus Cells from Oxidative Stress and Apoptosis by Activating Keap1-Nrf2 Signaling.
Kang L; Tian Y; Guo X; Chu X; Xue Y
Oxid Med Cell Longev; 2021; 2021():6645005. PubMed ID: 33603950
[TBL] [Abstract][Full Text] [Related]
39. miR-200a regulates Nrf2 activation by targeting Keap1 mRNA in breast cancer cells.
Eades G; Yang M; Yao Y; Zhang Y; Zhou Q
J Biol Chem; 2011 Nov; 286(47):40725-33. PubMed ID: 21926171
[TBL] [Abstract][Full Text] [Related]
40. lncRNAs and microRNAs with a role in cancer development.
Liz J; Esteller M
Biochim Biophys Acta; 2016 Jan; 1859(1):169-76. PubMed ID: 26149773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
